Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonardo Calza

Showing results (151-160 of 188) with videos related to

Pageof 19
Sort By:
Current HIV Research|December 7, 2017
Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected PatientsIsabella Bon, Leonardo Calza, Giuseppina Musumeci, et al.
The New Microbiologica|February 21, 2017
HIV and kidney: a dangerous liaisonAlessia Bertoldi, Elisa De Crignis, Anna Miserocchi, et al.
Current HIV Research|November 5, 2015
Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus EfavirenzLeonardo Calza, Eleonora Magistrelli, Ilaria Danese, et al.
Infection|August 5, 2020
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern ItalyLeonardo Calza, Isabella Bon, Marina Tadolini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2025
All-Cause Mortality in People with Four-Class Drug-Resistant HIV: A Matched Cohort Analysis with Data from the PRESTIGIO RegistryAndrea Giacomelli, Nicolò Capra, Riccardo Lolatto, et al.
AIDS Reviews|August 8, 2014
Novel antiretroviral drugs and renal function monitoring of HIV patientsPaolo Maggi, Vincenzo Montinaro, Cristina Mussini, et al.
Infectious Diseases (London, England)|December 7, 2017
Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapyLeonardo Calza, Matteo Cafaggi, Vincenzo Colangeli, et al.
The New Microbiologica|July 7, 2015
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patientsAlberto Clò, Davide Gibellini, Davide Damiano, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2020
Simplification to High Genetic Barrier 2-Drug Regimens in People Living With HIV Harboring 4-Class Resistance Enrolled in the PRESTIGIO RegistryDiana Canetti, Laura Galli, Nicola Gianotti, et al.
AIDS Reviews|February 3, 2012
Renal complications in HIV disease: between present and futurePaolo Maggi, Dario Bartolozzi, Paolo Bonfanti, et al.
Pageof 19

Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
Current HIV Research|December 7, 2017
Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected PatientsIsabella Bon, Leonardo Calza, Giuseppina Musumeci, et al.
The New Microbiologica|February 21, 2017
HIV and kidney: a dangerous liaisonAlessia Bertoldi, Elisa De Crignis, Anna Miserocchi, et al.
Current HIV Research|November 5, 2015
Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus EfavirenzLeonardo Calza, Eleonora Magistrelli, Ilaria Danese, et al.
Infection|August 5, 2020
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern ItalyLeonardo Calza, Isabella Bon, Marina Tadolini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2025
All-Cause Mortality in People with Four-Class Drug-Resistant HIV: A Matched Cohort Analysis with Data from the PRESTIGIO RegistryAndrea Giacomelli, Nicolò Capra, Riccardo Lolatto, et al.
AIDS Reviews|August 8, 2014
Novel antiretroviral drugs and renal function monitoring of HIV patientsPaolo Maggi, Vincenzo Montinaro, Cristina Mussini, et al.
Infectious Diseases (London, England)|December 7, 2017
Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapyLeonardo Calza, Matteo Cafaggi, Vincenzo Colangeli, et al.
The New Microbiologica|July 7, 2015
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patientsAlberto Clò, Davide Gibellini, Davide Damiano, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2020
Simplification to High Genetic Barrier 2-Drug Regimens in People Living With HIV Harboring 4-Class Resistance Enrolled in the PRESTIGIO RegistryDiana Canetti, Laura Galli, Nicola Gianotti, et al.
AIDS Reviews|February 3, 2012
Renal complications in HIV disease: between present and futurePaolo Maggi, Dario Bartolozzi, Paolo Bonfanti, et al.
Pageof 19